Skip to main content
Caplight Logo









Amplitude Therapeutics

Amplitude Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.amplitude-tx.com/

Last Round

Grant

Nov 1, 2024

Total Funding Raised

$3.77M

Company Overview

Amplitude Therapeutics is a biotechnology company that develops ribonucleic acid medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

trans-amplifying RNAtaRNARNA platformRNA vaccinesvaccine developmentnext-generation RNApandemic preparednessRNA therapeuticsRNA 2.0split-vector RNAdrug discovery platformmonoclonal antibody deliveryprotein replacement therapybiotechnology licensingpreclinical biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplitude Therapeutics Comparables

Compare Amplitude Therapeutics with similar companies based on industry and business-model similarity.

Amplitude Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Replicate Bioscience
83%
Ziphius Vaccines
80%
Eli Lilly and Company
77%

Amplitude Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2024
GrantAug 20, 2024
GrantMar 7, 2024
SeedMar 7, 2024

Amplitude Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2024

    Secured $2.04M in grant funding.

  • Aug 20, 2024

    $733K grant round completed.

Amplitude Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amplitude Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplitude Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2022
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?